Previous 10 | Next 10 |
home / stock / crtpf / crtpf news
The following slide deck was published by Cardiol Therapeutics Inc. in conjunction with this Read more ...
Grit Capital's Live-Stream Virtual Investor Conference June 26th Canada NewsWire NEW YORK, June 21, 2019 9 Company Executives of small cap millennial themed companies share their vision and answer questions live at VirtualInvestorConferences.com NEW YORK , June 21, 2019 ...
Oakville, Ontario--(Newsfile Corp. - June 20, 2019) - Cardiol Therapeutics Inc. ( TSX: CRDL) (OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the research and commercial development of pharmaceutical cannabidiol (CBD) and targeted therapies for heart disease, is pleased to announc...
Welcome to Wall Street Brunch, our preview of stock market events for investors to watch during the upcoming week. You can also catch this article a day early by subscribing to the Stocks to Watch account for Saturday morning delivery. Podcast listener? Subscribe now to receive Wall ...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you ca...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...
Oakville, Ontario--(Newsfile Corp. - June 13, 2019) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (" Cardiol " or the " Company "), a leader in the research and commercial development of pharmaceutical CBD and targeted therapies for heart disease, announces results from its Annual G...
Oakville, Ontario--(Newsfile Corp. - June 10, 2019) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the research and commercial development of pharmaceutical CBD and targeted therapies for inflammatory diseases, is pleased to announce ...
Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing Canada NewsWire NEW YORK, June 6, 2019 Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations N...
OAKVILLE, Ontario , June 3, 2019 /PRNewswire/ -- Cardiol Therapeutics Inc. (TSX: CRDL; OTCQX: CRTPF) ("Cardiol" or the "Company") , a leader in the research and commercial development of pharmaceutical CBD and targeted therapies for inflammatory diseases, announces that David Elsley , P...
News, Short Squeeze, Breakout and More Instantly...
Cardiol Therapeutics Company Name:
CRTPF Stock Symbol:
OTCMKTS Market:
Oakville, Ontario--(Newsfile Corp. - August 9, 2021) - Cardiol Therapeutics Inc. ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, announced to...
Oakville, Ontario--(Newsfile Corp. - July 7, 2021) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) ( FSE: CT9 ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardio...
Oakville, Ontario--(Newsfile Corp. - June 30, 2021) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) ( FSE: CT9 ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardi...